Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Serum la levels during tumor growth in mice and humans

Abstract

Antigen stimulation in mice such as occurs with the rejection of an allogeneic tumor graft caused a substantial rise in serum glycolipid la levels. However, mice bearing a measurable syngeneic tumor had no detectable la antigens in their sera; this observation was made in several different strains of inbred mice with 5 different tumors. In each instance the serum la level fell as the tumor grew progressively, reached zero at about the time the tumor was visible, and remained at this zero level until the mouse died. Similar results were found in humans: Tumor-bearing patients had markedly suppressed serum la levels. The mechanism of the fall in serum la glycolipid levels is not known, but the measurement of the serum la glycolipid content appears to reflect the level of activation of the immune system, and the suppression of serum glycolipid la levels found in tumorbearing mice and patients may have important clinical implications. JNCI 1981; 66:279-283.

Description

Keywords

Citation

Source

Journal of the National Cancer Institute

Book Title

Entity type

Access Statement

License Rights

Restricted until